The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Open accessAbstract
The 2021 World Health Organisation (WHO) Classification of Thoracic Tumours was published earlier this year, with classification of lung tumors being one of the chapters. The principles remain those of using morphology first, supported by immunohistochemistry and then molecular techniques. In 2015, there was particular emphasis on using immunohistochemistry to make classification more accurate. In 2021, there is greater emphasis throughout the book on advances in molecular pathology across all tumor types. Major features within this edition are 1) broader emphasis on genetic testing than in the 2015 WHO Classification, 2) a chapter entirely dedicated to the classification of small diagnostic samples, 3) continued recommendation to document percentages of histological patterns in invasive non-mucinous adenocarcinomas, with utilization of these features to apply a formal grading system, as well as using only invasive size for T-factor size determination in part lepidic non-mucinous lung adenocarcinomas as recommended by the 8th Edition TNM Classification, 4) recognition of spread through airspaces (STAS) as a histological feature with prognostic significance, 5) moving lymphoepithelial carcinoma to squamous cell carcinomas, 6) update on evolving concepts in lung neuroendocrine neoplasm classification, 7) recognition of bronchiolar adenoma/ciliated muconodular papillary tumor (BA/CMPT) as a new entity within the adenoma subgroup, 8) recognition of thoracic SMARCA4-deficient undifferentiated tumor, and 9) inclusion of essential and desirable diagnostic criteria for each tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer
Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M. J., Powell, S. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801005 · Cited by 6,607 · cited 3×
“As with EGFR mutation, ALK translocations preclude first-line therapy with ICIs.(125) Although other oncogenic alterations may be associated with reduced response to ICIs, they do not affect decisions in first-line therapy with ICI.”
BackgroundHerbst, R. S., Baas, P., Kim, D.-W., Felip, E., Pérez-Gracia, J. L., Han, J.-Y., Molina, J., Kim, J.-H., Arvis, C. D., Ahn, M.-J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01281-7 · Cited by 6,449
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationGoldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W. E. E., Nicholson, A. G., Groome, P., Mitchell, A., Bolejack, V., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.009 · Cited by 4,607
Self-citationPao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
The 2019 WHO classification of tumours of the digestive system
Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K. M., Carneiro, F., Cree, I. A., & the WHO Classification of Tumours Editorial Board (2020) · Histopathology · doi:10.1111/his.13975 · Cited by 4,192
Mok, T. S. K., Wu, Y.-L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., Castro, G., Srimuninnimit, V., Laktionov, K. K., Bondarenko, I., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32409-7 · Cited by 3,303
Nivolumab plus ipilimumab in advanced non-small-cell lung cancer
Hellmann, M. D., Paz-Ares, L., Bernabe Caro, R., Zurawski, B., Kim, S.-W., Carcereny Costa, E., Park, K., Alexandru, A., Lupinacci, L., de la Mora Jimenez, E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910231 · Cited by 2,823
Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E. F., Faivre-Finn, C., Mok, T. S., Reck, M., Van Schil, P. E., Hellmann, M. D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy275 · Cited by 2,274
Self-citationCrizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
Wu, Y.-L., Tsuboi, M., He, J., John, T., Grohe, C., Majem, M., Goldman, J. W., Laktionov, K., Kim, S.-W., Kato, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2027071 · Cited by 1,798
KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
Hong, D. S., Fakih, M. G., Strickler, J. H., Desai, J., Durm, G. A., Shapiro, G. I., Falchook, G. S., Price, T. J., Sacher, A., Denlinger, C. S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917239 · Cited by 1,733
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Herbst, R. S., Giaccone, G., de Marinis, F., Reinmuth, N., Vergnenegre, A., Barrios, C. H., Morise, M., Felip, E., Andric, Z., Geater, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917346 · Cited by 1,664
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
Skoulidis, F., Goldberg, M. E., Greenawalt, D. M., Hellmann, M. D., Awad, M. M., Gainor, J. F., Schrock, A. B., Hartmaier, R. J., Trabucco, S. E., Gay, L., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0099 · Cited by 1,641
Self-citationPD-L1 as a biomarker of response to immune-checkpoint inhibitors
Doroshow, D. B., Bhalla, S., Beasley, M. B., Sholl, L. M., Kerr, K. M., Gnjatic, S., Wistuba, I. I., Rimm, D. L., Tsao, M. S., & Hirsch, F. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00473-5 · Cited by 1,575
Self-citationRudin, C. M., Brambilla, E., Faivre-Finn, C., & Sage, J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00235-0 · Cited by 1,570
Self-citationMazieres, J., Drilon, A., Lusque, A., Mhanna, L., Cortot, A. B., Mezquita, L., Thai, A. A., Mascaux, C., Couraud, S., Veillon, R., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz167 · Cited by 1,354
RET, ROS1 and ALK fusions in lung cancer
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Rudin, C. M., Poirier, J. T., Byers, L. A., Dive, C., Dowlati, A., George, J., Heymach, J. V., Johnson, J. E., Lehman, J. M., MacPherson, D., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0133-9 · Cited by 1,254
Rindi, G., Klimstra, D. S., Abedi-Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E., Busam, K. J., de Krijger, R. R., Dietel, M., El-Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,163
Self-citationFirst-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Bauer, T. M., de Marinis, F., Felip, E., Goto, Y., Liu, G., Mazieres, J., Kim, D.-W., Mok, T., Polli, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2027187 · Cited by 1,099
Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer
Wolf, J., Seto, T., Han, J.-Y., Reguart, N., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Hida, T., de Jonge, M., Orlov, S. V., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002787 · Cited by 1,000
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Self-citationGay, C. M., Stewart, C. A., Park, E. M., Diao, L., Groves, S. M., Heeke, S., Nabet, B. Y., Fujimoto, J., Solis, L. M., Lu, W., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.014 · Cited by 962
Planchard, D., Besse, B., Groen, H. J. M., Souquet, P.-J., Quoix, E., Baik, C. S., Barlesi, F., Kim, T. M., Mazieres, J., Novello, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30146-2 · Cited by 888
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
Drilon, A., Oxnard, G. R., Tan, D. S. W., Loong, H. H. F., Johnson, M., Gainor, J., McCoach, C. E., Gautschi, O., Besse, B., Cho, B. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2005653 · Cited by 828
Travis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., & Koss, M. N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00003 · Cited by 807
Self-citationSezer, A., Kilickap, S., Gümüş, M., Bondarenko, I., Özgüroğlu, M., Gogishvili, M., Turk, H. M., Cicin, I., Bentsion, D., Gladkov, O., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00228-2 · Cited by 789
Travis, W. D., Asamura, H., Bankier, A. A., Beasley, M. B., Detterbeck, F., Flieder, D. B., Goo, J. M., MacMahon, H., Naidich, D., Nicholson, A. G., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.03.025 · Cited by 722
Self-citationCaplin, M. E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., Oberg, K., Pelosi, G., Perren, A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 714
Self-citationClinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paik, P. K., Arcila, M. E., Fara, M., Sima, C. S., Miller, V. A., Kris, M. G., Ladanyi, M., & Riely, G. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1280 · Cited by 691
Rodig, S. J., Mino-Kenudson, M., Dacic, S., Yeap, B. Y., Shaw, A., Barletta, J. A., Stubbs, H., Law, K., Lindeman, N., Mark, E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0802 · Cited by 678
Self-citationKadota, K., Nitadori, J.-I., Sima, C. S., Ujiie, H., Rizk, N. P., Jones, D. R., Adusumilli, P. S., & Travis, W. D. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000486 · Cited by 673
Self-citationLindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.001 · Cited by 645
Self-citationJordan, E. J., Kim, H. R., Arcila, M. E., Barron, D., Chakravarty, D., Gao, J., Chang, M. T., Ni, A., Kundra, R., Jonsson, P., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1337 · Cited by 643
Self-citationDogan, S., Shen, R., Ang, D. C., Johnson, M. L., D'Angelo, S. P., Paik, P. K., Brzostowski, E. B., Riely, G. J., Kris, M. G., Zakowski, M. F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3265 · Cited by 639
Paik, P. K., Drilon, A., Fan, P.-D., Yu, H., Rekhtman, N., Ginsberg, M. S., Borsu, L., Schultz, N., Berger, M. F., Rudin, C. M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1467 · Cited by 575
Self-citationMoreira, A. L., Ocampo, P. S. S., Xia, Y., Zhong, H., Russell, P. A., Minami, Y., Cooper, W. A., Yoshida, A., Bubendorf, L., Papotti, M., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.06.001 · Cited by 559
Self-citationRET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
Wang, R., Hu, H., Pan, Y., Li, Y., Ye, T., Li, C., Luo, X., Wang, L., Li, H., Zhang, Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1477 · Cited by 546
Baine, M. K., Hsieh, M.-S., Lai, W. V., Egger, J. V., Jungbluth, A. A., Daneshbod, Y., Beras, A., Spencer, R., Lopardo, J., Bodd, F., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.09.009 · Cited by 522
Self-citationGenomic landscape of lung adenocarcinoma in East Asians
Chen, J., Yang, H., Teo, A. S. M., Amer, L. B., Sherbaf, F. G., Tan, C. Q., Alvarez, J. J. S., Lu, B., Lim, J. Q., Takano, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0569-6 · Cited by 509
Marcoux, N., Gettinger, S. N., O’Kane, G., Arbour, K. C., Neal, J. W., Husain, H., Evans, T. L., Brahmer, J. R., Muzikansky, A., Bonomi, P. D., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01585 · Cited by 500
Rekhtman, N., Pietanza, M. C., Hellmann, M. D., Naidoo, J., Arora, A., Won, H., Halpenny, D. F., Wang, H., Tian, S. K., Litvak, A. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2946 · Cited by 487
Self-citationHanna, N. H., Schneider, B. J., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Gaspar, L. E., Haddad, R. Y., Hesketh, P. J., Jain, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03022 · Cited by 456
Self-citationYoshizawa, A., Sumiyoshi, S., Sonobe, M., Kobayashi, M., Fujimoto, M., Kawakami, F., Tsuruyama, T., Travis, W. D., Date, H., & Haga, H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182769aa8 · Cited by 436
Self-citationTravis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Ishikawa, Y., Wistuba, I., Flieder, D. B., Franklin, W., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0263-ra · Cited by 414
Self-citationLe Loarer, F., Watson, S., Pierron, G., de Montpreville, V. T., Ballet, S., Firmin, N., Auguste, A., Pissaloux, D., Boyault, S., Paindavoine, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3399 · Cited by 378
Self-citationGeorge, J., Walter, V., Peifer, M., Alexandrov, L. B., Seidel, D., Leenders, F., Maas, L., Müller, C., Dahmen, I., Delhomme, T. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03099-x · Cited by 377
Self-citationNCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
Shah, M. H., Goldner, W. S., Halfdanarson, T. R., Bergsland, E., Berlin, J. D., Halperin, D., Chan, J., Kulke, M. H., Benson, A. B., Blaszkowsky, L. S., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0056 · Cited by 375
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yatabe, Y., Dacic, S., Borczuk, A. C., Warth, A., Russell, P. A., Lantuejoul, S., Beasley, M. B., Thunnissen, E., Pelosi, G., Rekhtman, N., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.005 · Cited by 365
Self-citationPD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
Lantuejoul, S., Sound-Tsao, M., Cooper, W. A., Girard, N., Hirsch, F. R., Roden, A. C., Lopez-Rios, F., Jain, D., Chou, T.-Y., Motoi, N., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.12.107 · Cited by 332
Self-citationRekhtman, N., Montecalvo, J., Chang, J. C., Alex, D., Ptashkin, R. N., Ai, N., Sauter, J. L., Kezlarian, B., Jungbluth, A., Desmeules, P., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.10.023 · Cited by 326
Self-citationEllison, G., Zhu, G., Moulis, A., Dearden, S., Speake, G., & McCormack, R. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201194 · Cited by 301
Eguchi, T., Kameda, K., Lu, S., Bott, M. J., Tan, K. S., Montecalvo, J., Chang, J. C., Rekhtman, N., Jones, D. R., Travis, W. D., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.005 · Cited by 300
Self-citationSchoenfeld, A. J., Bandlamudi, C., Lavery, J. A., Montecalvo, J., Namakydoust, A., Rizvi, H., Egger, J., Concepcion, C. P., Paul, S., Arcila, M. E., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1825 · Cited by 296
Self-citationPrognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma
Warth, A., Muley, T., Kossakowski, C. A., Goeppert, B., Schirmacher, P., Dienemann, H., & Weichert, W. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000409 · Cited by 293
Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma
Snyder, E. L., Watanabe, H., Magendantz, M., Hoersch, S., Chen, T. A., Wang, D. G., Crowley, D., Whittaker, C. A., Meyerson, M., Kimura, S., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.018 · Cited by 268
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
Kohno, T., Nakaoku, T., Tsuta, K., Tsuchihara, K., Matsumoto, S., Yoh, K., & Goto, K. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2014.11.11 · Cited by 263
Tsuta, K., Kawago, M., Inoue, E., Yoshida, A., Takahashi, F., Sakurai, H., Watanabe, S.-I., Takeuchi, M., Furuta, K., Asamura, H., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.06.012 · Cited by 240
Self-citationRekhtman, N., Brandt, S. M., Sigel, C. S., Friedlander, M. A., Riely, G. J., Travis, W. D., Zakowski, M. F., & Moreira, A. L. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820517a3 · Cited by 236
Self-citationYoshida, A., Kobayashi, E., Kubo, T., Kodaira, M., Motoi, T., Motoi, N., Yonemori, K., Ohe, Y., WATANABE, S.-I. I., Kawai, A., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.11 · Cited by 233
Self-citationDerks, J. L., Leblay, N., Thunnissen, E., van Suylen, R. J., den Bakker, M., Groen, H. J. M., Smit, E. F., Damhuis, R., van den Broek, E. C., Charbrier, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1921 · Cited by 232
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
Loo, P. S., Thomas, S. C., Nicolson, M. C., Fyfe, M. N., & Kerr, K. M. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d40fac · Cited by 226
Self-citationAlcala, N., Leblay, N., Gabriel, A. A. G., Mangiante, L., Hervas, D., Giffon, T., Sertier, A. S., Ferrari, A., Derks, J., Ghantous, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11276-9 · Cited by 224
Self-citationK-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
Westra, W. H., Baas, I. O., Hruban, R. H., Askin, F. B., Wilson, K. H., Offerhaus, G. J. A., & Slebos, R. J. C. (1996) · PubMed · Cited by 223
Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an NTRK Gene Fusion
Farago, A. F., Taylor, M. S., Doebele, R. C., Zhu, V. W., Kummar, S., Spira, A. I., Boyle, T. A., Haura, E. B., Arcila, M. E., Benayed, R., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.18.00037 · Cited by 222
Pan, Y., Zhang, Y., Li, Y., Hu, H., Wang, L., Li, H., Wang, R., Ye, T., Luo, X., Zhang, Y., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.02.007 · Cited by 217
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
Rindi, G., Klersy, C., Inzani, F., Fellegara, G., Ampollini, L., Ardizzoni, A., Campanini, N., Carbognani, P., De Pas, T. M., Galetta, D., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0246 · Cited by 217
Self-citationNicholson, A. G., Gonzalez, D., Shah, P., Pynegar, M. J., Deshmukh, M., Rice, A., & Popat, S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c6ed9b · Cited by 215
Self-citationAisner, D. L., Sholl, L. M., Berry, L. D., Rossi, M. R., Chen, H., Fujimoto, J., Moreira, A. L., Ramalingam, S. S., Villaruz, L. C., Otterson, G. A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2289 · Cited by 206
Self-citationDruggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Nakaoku, T., Tsuta, K., Ichikawa, H., Shiraishi, K., Sakamoto, H., Enari, M., Furuta, K., Shimada, Y., Ogiwara, H., Watanabe, S.-I., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0107 · Cited by 206
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung
Shim, H. S., Kenudson, M., Zheng, Z., Liebers, M., Cha, Y. J., Hoang Ho, Q., Onozato, M., Phi Le, L., Heist, R. S., & Iafrate, A. J. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000579 · Cited by 203
Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice
Pelosi, G., Rindi, G., Travis, W. D., & Papotti, M. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000092 · Cited by 203
Self-citationSauter, J. L., Graham, R. P., Larsen, B. T., Jenkins, S. M., Roden, A. C., & Boland, J. M. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.61 · Cited by 197
Yatabe, Y., Kerr, K. M., Utomo, A., Rajadurai, P., Tran, V. K., Du, X., Chou, T.-Y., Enriquez, M. L. D., Lee, G. K., Iqbal, J., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000422 · Cited by 182
Self-citationRossi, G., Murer, B., Cavazza, A., Losi, L., Natali, P., Marchioni, A., Migaldi, M., Capitanio, G., & Brambilla, E. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00003 · Cited by 180
Self-citationMulti-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Hu, X., Fujimoto, J., Ying, L., Fukuoka, J., Ashizawa, K., Sun, W., Reuben, A., Chow, C.-W., McGranahan, N., Chen, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10877-8 · Cited by 173
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
Poirier, J. T., George, J., Owonikoko, T. K., Berns, A., Brambilla, E., Byers, L. A., Carbone, D., Chen, H. J., Christensen, C. L., Dive, C., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.01.016 · Cited by 173
Self-citationYAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype
Owonikoko, T. K., Dwivedi, B., Chen, Z., Zhang, C., Barwick, B., Ernani, V., Zhang, G., Gilbert-Ross, M., Carlisle, J., Khuri, F. R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.11.006 · Cited by 166
Carrot‐Zhang, J., Soca‐Chafre, G., Patterson, N. J., Thorner, A. R., Nag, A., Watson, J., Genovese, G., Rodríguez, J. K., Gelbard, M. K., Corrales, L., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1165 · Cited by 164
Counting mitoses: SI(ze) matters!
Cree, I. A., Tan, P. H., Travis, W. D., Wesseling, P., Yagi, Y., White, V. A., Lokuhetty, D., & Scolyer, R. A. (2021) · Modern Pathology · doi:10.1038/s41379-021-00825-7 · Cited by 156
Self-citationZhao, Y., Wang, R., Shen, X., Pan, Y., Cheng, C., Li, Y., Shen, L., Zhang, Y., Li, H., Zheng, D., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-015-5043-9 · Cited by 155
Derks, J. L., Leblay, N., Lantuéjoul, S., Dingemans, A. C., Speel, E. M., & Fernandez‐Cuesta, L. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.02.002 · Cited by 155
Characteristics of Lung Cancers Harboring NRAS Mutations
Ohashi, K., Sequist, L. V. D., Arcila, M. E., Lovly, C. M., Chen, X., Rudin, C. M., Morán, T., Camidge, D. R., Vnencak‐Jones, C. L., Berry, L. D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3173 · Cited by 153
The Influence of Rapid Onsite Evaluation on the Adequacy Rate of Fine-Needle Aspiration Cytology
Schmidt, R. L., Witt, B. L., Lopez-Calderon, L. E., & Layfield, L. J. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpegzmjkc42vup · Cited by 149
MAP2K1 ( MEK1 ) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking
Arcila, M. E., Drilon, A. E. D. C., Sylvester, B. E., Lovly, C. M., Borsu, L. A., Reva, B. A., Kris, M. G., Solit, D. B., & Ladanyi, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2124 · Cited by 148
Primary Pulmonary Myxoid Sarcoma With EWSR1-CREB1 Fusion
Thway, K., Nicholson, A. G., Lawson, K., de Castro, D. G., Rice, A. J., Balzer, B. L., Swansbury, J. G., Min, T., Thompson, L., Kwame, A.-P., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318227e4d2 · Cited by 142
Self-citationEdwards, S., Roberts, C., McKean, M. E., Cockburn, J. S., Jeffrey, R. R., & Kerr, K. M. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.7.537 · Cited by 140
Self-citationChang, J. C., Montecalvo, J., Borsu, L. A., Lu, S., Larsen, B. T., Wallace, W. D., Sae‐Ow, W., Mackinnon, A. C., Kim, H. R., Bowman, A. S., et al. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001086 · Cited by 140
Self-citationWen, S., Dai, L., Wang, L., Wang, W., Wu, D., Wang, K., He, Z., Wang, A., Chen, H., Zhang, P., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0572 · Cited by 140
Russell, P. A., Barnett, S. A., Walkiewicz, M., Wainer, Z., Conron, M., Wright, G. M., Gooi, J. H., Knight, S., Wynne, R. M., Liew, D., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182828fb8 · Cited by 133
Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
Lee, S. E., Lee, B., Hong, M. E., Song, J., Jung, K., Lira, M. E., Mao, M., Han, J., Kim, J., & Choi, Y. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.107 · Cited by 131
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
Mescam-Mancini, L., Lantuéjoul, S., Moro‐Sibilot, D., Rouquette, I., Souquet, P.-J., Audigier-Valette, C., Sabourin, J., Decroisette, C., Sakhri, L., Brambilla, E. M., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.019 · Cited by 122
Self-citationPark, K., Vansteenkiste, J., Lee, K. H., Pentheroudakis, G., Zhou, C., Prabhash, K., Seto, T., Voon, P. J., Tan, D. S. W., Yang, J. C., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.026 · Cited by 121
Rekhtman, N., Ang, D. C., Riely, G. J., Ladanyi, M., & Moreira, A. L. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.74 · Cited by 117
Self-citationComprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma
Li, S., Choi, Y., Gong, Z., Liu, X., Lira, M. E., Kan, Z., Oh, E., Wang, J., Ting, J. C., Ye, X. S., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.142 · Cited by 115
Chang, J. C., Offin, M. D., Falcon, C. J., Brown, D. N., Houck-Loomis, B. R., Meng, F., Rudneva, V. A., Won, H. H., Amir, S., Montecalvo, J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0423 · Cited by 115
Self-citationSimbolo, M., Barbi, S., Fassan, M., Mafficini, A., Alì, G., Vicentini, C., Sperandio, N., Corbo, V., Rusev, B. C., Mastracci, L., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.003 · Cited by 111
Aly, R. G. M., Rekhtman, N., Li, X., Takahashi, Y., Eguchi, T., Tan, K. S., Rudin, C. M., Adusumilli, P. S., & Travis, W. D. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.009 · Cited by 107
Self-citationLantuéjoul, S., Fernandez‐Cuesta, L., Damiola, F., Girard, N., & Leer, A. M. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-269 · Cited by 99
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung
Hwang, D. H., Sholl, L. M., Rojas‐Rudilla, V., Hall, D. L., Shivdasani, P., Garcia, E. P., MacConaill, L. E., Vivero, M., Hornick, J. L., Kuo, F. C., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.010 · Cited by 93
Self-citationChang, J. C., Zhang, L., Drilon, A. E. D. C., Chi, P., Alaggio, R., Borsu, L. A., Benayed, R., Travis, W. D., Ladanyi, M., & Antonescu, C. R. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.003 · Cited by 89
Self-citationFrequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung
Kamata, T., Sunami, K., Yoshida, A., Shiraishi, K., Furuta, K., Shimada, Y., Katai, H., WATANABE, S.-I. J., Asamura, H., Kohno, T., et al. (2015) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.10.021 · Cited by 80
Self-citationSample features associated with success rates in population-based EGFR mutation testing
Shiau, C. J., Babwah, J. P., da Cunha Santos, G., Sykes, J. R., Boerner, S. L., Geddie, W. R., Leighl, N. B., Wei, C., Kamel-Reid, S., Hwang, D. M., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000196 · Cited by 78
Self-citationCharacterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
Robelin, P., Hadoux, J., Forestier, J., Planchard, D., Hervieu, V., Berdelou, A., Scoazec, J., Valette, P., Leboulleux, S., Ducreux, M. P., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.02.002 · Cited by 75
Bulman, W. A., Saqi, A., & Powell, C. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1199ci · Cited by 73
Bains, S., Eguchi, T., Warth, A., Yeh, Y., Nitadori, J., Woo, K. M., Chou, T., Dienemann, H., Muley, T., Nakajima, J., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.008 · Cited by 72
Self-citationSong, Z., Zhu, H., Guo, Z., Wu, W., Sun, W., & Zhang, Y. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.08.026 · Cited by 71
Pearsall, S. M., Humphrey, S., Revill, M., Morgan, D., Frese, K. K., Galvin, M., Kerr, A. R. W., Carter, M., Priest, L. J. C., Blackhall, F. H., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.07.008 · Cited by 71
Schneider, F., Derrick, V., Davison, J. M., Strollo, D. C., Incharoen, P., & Đačić, S. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.66 · Cited by 67
Wang, W., Hu, Z., Zhao, J., Huang, Y., Rao, S., Yang, J., Xiao, S., Cao, R., & Ye, L. (2020) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-020-01199-8 · Cited by 65
Baine, M. K., & Rekhtman, N. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2020.02.13 · Cited by 63
Self-citationThe Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors
Dermawan, J. K. T. K., & Farver, C. F. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001358 · Cited by 62
Turner, S. R., Buonocore, D. J., Desmeules, P., Rekhtman, N., Doğan, S., Lin, O., Arcila, M. E., Jones, D. R., & Huang, J. G. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.03.003 · Cited by 59
Self-citationGenomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma
Qian, J., Zhao, S., Zou, Y., Rahman, S. M. J., Senosain, M.-F., Stricker, T. P., Chen, H., Powell, C. A., Borczuk, A., & Massion, P. P. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0294oc · Cited by 59
Self-citationAsmar, R., Sonett, J. R., Singh, G., MANSUKHANI, M. M., & Borczuk, A. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.06.012 · Cited by 58
Self-citationLeeman, J. E., Rimner, A., Montecalvo, J., Hsu, M., Zhang, Z., von Reibnitz, D., Panchoo, K., Yorke, E. D., Adusumilli, P. S., Travis, W. D., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.09.037 · Cited by 54
Self-citationCros, J. F., Théou–Anton, N., Gounant, V., Nicolle, R., Réyès, C., Humez, S., Hescot, S., de Montpréville, V., Guyétant, S., Scoazec, J., et al. (2020) · Neuroendocrinology · doi:10.1159/000506292 · Cited by 52
Pisapia, P., Malapelle, U., Roma, G., Saddar, S., Zheng, Q., Pepe, F., Bruzzese, D., Vigliar, E., Bellevicine, C., Luthra, R., et al. (2019) · Cancer Cytopathology · doi:10.1002/cncy.22134 · Cited by 51
Self-citationChen, M., Liu, P., Yan, F., Xu, S., Jiang, Q., Pan, J., He, M., & Shen, P. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1449-z · Cited by 48
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non–Small Cell Lung Cancer
Martin-Deleon, R., Teixidó, C., Lucena, C. M., Martínez, D., Fontana, A., Reyes, R., García, M., Viñolas, N., Vollmer, I., Sánchez, M., et al. (2021) · Cancers · doi:10.3390/cancers13092084 · Cited by 47
Matsubara, D., Soda, M., Yoshimoto, T., Amano, Y., Sakuma, Y., Yamato, A., Ueno, T., Kojima, S., Shibano, T., Hosono, Y., et al. (2017) · Cancer Science · doi:10.1111/cas.13313 · Cited by 44
Yang, S., Chang, J. C., Leduc, C., Tan, K. S., Doğan, S., Benayed, R., Borsu, L. A., Offin, M. D., Drilon, A. E. D. C., Travis, W. D., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.03.023 · Cited by 42
Self-citationJurmeister, P. S., Vollbrecht, C., Behnke, A., Frost, N., Arnold, A., Treue, D., Rückert, J., Neudecker, J., Schweizer, L., Klauschen, F., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.10.005 · Cited by 41
Santos, G. D. C., & Saieg, M. A. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21595 · Cited by 40
Jeffus, S. K., Joiner, A. K., Siegel, E. R., Massoll, N. A., Meena, N. K., Chen, C., Post, S. R., & Bartter, T. C. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21555 · Cited by 39
Yang, C., Sánchez-Vega, F., Chang, J. C., Chatila, W. K., Shoushtari, A. N., Ladanyi, M., Travis, W. D., BUSAM, K. J., & Rekhtman, N. (2020) · Modern Pathology · doi:10.1038/s41379-020-0594-0 · Cited by 39
Self-citationYuan, Y., Ma, G., Zhang, Y., & Chen, H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2571-7 · Cited by 38
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms
Baudin, É., Hayes, A. R., Scoazec, J., Filosso, P. L., Lim, E. K. S., Kaltsas, G., Frilling, A., Chen, J., Kos‐Kudła, B., Gorbunova, V. A., et al. (2018) · Neuroendocrinology · doi:10.1159/000493980 · Cited by 35
de Montpréville, V., Lacroix, L., Rouleau, É., Mamodaly, M., Leclerc, J., Tutuianu, L., Planchard, D., Boulate, D., Mercier, O. M., Besse, B., et al. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151522 · Cited by 34
Pentheroudakis, G. E. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.05.023 · Cited by 34
Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung
Sakuma, Y., Matsukuma, S., Yoshihara, M., Nakamura, Y., Nakayama, H., Kameda, Y., Tsuchiya, E., & Miyagi, Y. (2007) · Modern Pathology · doi:10.1038/modpathol.3800929 · Cited by 33
Baine, M. K., Sinard, J. H., Cai, G., & Homer, R. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz149 · Cited by 31
Miyashita, N., Horie, M., Suzuki, H. I., Yoshihara, M., Djureinovic, D., Persson, J., Brunnström, H., Lindskog, C., Elfving, H., Micke, P., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.07.096 · Cited by 29
Shao, J., Yin, J. C., Bao, H., Zhao, R., Han, Y., Zhu, L., Wu, X., Shao, Y. W., & Zhang, J. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.197 · Cited by 27
Lin, D., Xing, X., Ran, W., Zhao, H., Li, G., Xu, J., Wang, Y., Shao, S., & Wang, J. (2020) · Histopathology · doi:10.1111/his.14098 · Cited by 26
Yatabe, Y. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.10.011 · Cited by 12
Self-citation
Cited by
Hendriks, L. E. L., Remon, J., Faivre-Finn, C., Garassino, M. C., Heymach, J. V., Kerr, K. M., Tan, D. S. W., Veronesi, G., & Reck, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00551-9 · Cited by 568
Self-citationGlobal variations in lung cancer incidence by histological subtype in 2020: a population-based study
Zhang, Y., Vaccarella, S., Morgan, E., Li, M., Etxeberria, J., Chokunonga, E., Manraj, S. S., Kamate, B., Omonisi, A., & Bray, F. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00444-8 · Cited by 445
A Graph-Transformer for Whole Slide Image Classification
Zheng, Y., Gindra, R. H., Green, E. J., Burks, E. J., Betke, M., Beane, J. E., & Kolachalama, V. B. (2022) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2022.3176598 · Cited by 255
Application of Artificial Intelligence in Lung Cancer
Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M. (2022) · Cancers · doi:10.3390/cancers14061370 · Cited by 138
PROTAC therapy as a new targeted therapy for lung cancer
Li, J. W., Zheng, G., Kaye, F. J., & Wu, L. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.011 · Cited by 87
Metadata
- Authors
- Nicholson, A. G., Tsao, M. S., Beasley, M. B., Borczuk, A. C., Brambilla, E., Cooper, W. A., Dacic, S., Jain, D., Kerr, K. M., Lantuejoul, S., Noguchi, M., Papotti, M., Rekhtman, N., Scagliotti, G., van Schil, P., Sholl, L., Yatabe, Y., Yoshida, A., & Travis, W. D.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 17
- Issue
- 3
- Pages
- 362-387
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W3215921195
- Cited by
- 1,554
- References
- 144
- FWCI
- 118.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.